Abstract
Acute respiratory distress syndrome (ARDS) continues to be a devastating acute lung process with high short-term mortality and potential for significant long-term consequences. Ventilator strategies are keystone in the treatment of this disease, along with other supportive therapies as adjuncts. The ability to quickly diagnose this syndrome with clinical data, including chest X-ray and computed tomography, is crucial for prompt initiation of appropriate treatments that could positively affect outcome. In this chapter, we review the current evidence base for such therapies, both pharmacological and non-pharmacological. We emphasize lung protective ventilation, the concept of low plateau pressures and low tidal volumes, and the benefit of positive end expiratory pressure (PEEP).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fanelli V, et al. Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis. 2013;5(3):326–34.
Donahoe M. Acute respiratory distress syndrome: a clinical review. Pulm Circ. 2011;1(2):192–211.
Bihari S, et al. Steroids in ARDS: to be or not to be. Intensive Care Med. 2016;42(5):931–3.
Truwit J, et al. SAILS: statins for acutely injured lungs (ARDS) from sepsis. Am J Respir Crit Care Med. 2014;189:A5088.
Mehta C, et al. Management of refractory hypoxemia. Ann Card Anesth. 2016;19(1):89–96.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Gomes, M.E. (2017). CXR/CT IV. In: Raj, T. (eds) Data Interpretation in Anesthesia. Springer, Cham. https://doi.org/10.1007/978-3-319-55862-2_47
Download citation
DOI: https://doi.org/10.1007/978-3-319-55862-2_47
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55861-5
Online ISBN: 978-3-319-55862-2
eBook Packages: MedicineMedicine (R0)